Asylia Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Asylia Therapeutics's estimated annual revenue is currently $387.5k per year.
- Asylia Therapeutics's estimated revenue per employee is $77,500
- Asylia Therapeutics's total funding is $22.7M.
Employee Data
- Asylia Therapeutics has 5 Employees.
- Asylia Therapeutics grew their employee count by 150% last year.
Asylia Therapeutics's People
| Name | Title | Email/Phone |
|---|
Asylia Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.5M | 16 | 45% | N/A | N/A |
#2 | $13.8M | 89 | -7% | N/A | N/A |
#3 | $18.6M | 120 | 3% | $1.8M | N/A |
#4 | $0.9M | 6 | -40% | N/A | N/A |
#5 | $4.2M | 27 | 0% | N/A | N/A |
#6 | $3.4M | 22 | 47% | N/A | N/A |
#7 | $9.6M | 62 | 29% | N/A | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $1.7M | 11 | 10% | N/A | N/A |
#10 | $15.2M | 98 | -8% | N/A | N/A |
What Is Asylia Therapeutics?
Asylia Therapeutics, established August 6, 2019, is a private, development-stage biotechnology company advancing novel immune modulating therapies for cancer and autoimmune diseases, which collectively impact millions of Americans annually. The company’s platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has, to date, produced remarkable anti-tumor responses across a spectrum of well established cancer models.
keywords:N/A
$22.7M
Total Funding
5
Number of Employees
$387.5k
Revenue (est)
150%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Houston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 5 | 0% | N/A |
#2 | $0.6M | 5 | -37% | N/A |
#3 | $0.5M | 5 | 0% | N/A |
#4 | $1.7M | 5 | -37% | N/A |
#5 | $0.3M | 5 | -44% | N/A |